Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Evaluating the Efficacy and Safety of 5 mg Levocetirizine Oral Tablets, Once Daily Versus 10 mg Loratadine Oral Tablets, Once Daily for the Treatment of Seasonal Allergic Rhinitis (SAR)

NCT00525278 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00525278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00525278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Evaluating the Efficacy and Safety of 5 mg Levocetirizine Oral Tablets, Once Daily Versus 10 mg Loratadine Oral Tablets, Once Daily for the Treatment of Seasonal Allergic Rhinitis (SAR)
Lead sponsor
UCB Pharma
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2003
Completion date
October 31, 2003
Enrollment
67 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergic, rhinitis, seasonal